Raycaster/ Eval

Company environment · Sterile injectable quality · NMPA / CDE

A generic sterile injection under review in China

Under review; answering a formal deficiency notice. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.

1What does this company do?

A generic drug company seeking approval in China for a sterile cancer-drug injection.

The injection is made by sterile filling into glass vials — under review, every claim in the filing has to trace to a record.

For experts

Chinese generics manufacturer under CDE review for a sterile oncology injection — a statutory 80-day deficiency clock with an on-site dynamic inspection ahead.

2Where is the product on its way to patients?

The application is under review, and China’s drug evaluation center has sent a deficiency notice.

  1. 1Discovery
  2. 2Lab & animal studies
  3. 3Human trials
  4. 4Filing & review
    • The product is here
  5. 5Approved
  6. 6On the market

The regulator asks for tighter impurity and contamination limits, process-hold evidence, container-leak testing, and packaging-chemicals data.

For experts

Sterile injectable in glass vials; jobs cover the deficiency-reply quality section, aseptic process validation, method and specification alignment, and container-closure integrity — each defensible from executed records.

3What is happening right now?

The deficiency notice has started an 80-day clock.

Each job answers part of the notice from executed records.

4Which jobs were the models given?

4 jobs, each graded against a specialist’s checklist.

Scores are checks passed out of checks in the list. Each model ran each job once.

JobSolOpusAstra
01Author the complete quality reply to the deficiency notice — formulation, process controls, release specs, and stability commitments.10/1210/1210/12
02Audit the aseptic compounding and filling validation record ahead of the on-site inspection — hold times, inert-atmosphere protection, yield.5/108/108/10
03Set the QC position on the method sensitivity and release limits the deficiency notice demands.6/106/108/10
04Evaluate the vial, stopper, and seal packaging against its qualification data — leak integrity, migration, shelf-life support.7/109/104/10

This company’s files stay private.

The jobs on this page are scored as part of the official 71-task benchmark. The files, the model’s steps, and each check stay unpublished, because they come from a real product’s records. To follow a job all the way down, open one of our open companion showcases (evaluated separately from the benchmark totals).

Havenor Therapeutics (fictional showcase) →
Broad Institute (public FDA record showcase) →

← Back to all company environments